Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04627064
Title ABEMA Alone or in COMBO With MK-6482
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Dana-Farber Cancer Institute
Indications

sarcomatoid renal cell carcinoma

clear cell renal cell carcinoma

Therapies

Abemaciclib + Belzutifan

Abemaciclib

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.